Mild Cognitive Impairment Clinical Trials in Miami, Florida

5 studies are recruiting for mild cognitive impairment in Miami, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY

   The overall goal of the DISCOVERY study is to better understand what factors contribute to changes in cognitive (i.e., thinking and memory) abilities in patients who experienced a stroke. The purpose of the study is to help doctors identify patients at risk for dementia (decline in memory, thinking…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Miami Health System, Miami, Florida

   Locations

   31 in total

   Run by

   Massachusetts General Hospital

   See if you can join NCT04916210 on ClinicalTrials.gov

2. Human Mesenchymal Stem Cells & Monoclonal Antibodies in the Treatment for Mild Cognitive Impairment or Early Alzheimer's Disease.

   The purpose of this study is to test if adding one infusion of (Human Mesenchymal Stem Cells) hMSCs to the treatment with standard of care (SOC) monoclonal antibodies (mAb) will stabilize the rate of cognitive and functional decline associated with mild Alzheimer's Disease.

   Stage

   Phase 2

   Ages

   55 to 90

   Site

   University of Miami Department of Neurology, Miami, Florida

   Run by

   Bernard (Barry) Baumel

   See if you can join NCT07512362 on ClinicalTrials.gov

3. Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia

   Bio-Hermes-002 is a 120-day cross-sectional study that will result in a blood, CSF, retinal, digital, MRI, and PET brain imaging biomarker database that can be used to determine the primary objective. Digital biomarkers and blood-based biomarkers will be tested to determine whether a meaningful rel…

   Stage

   Not phased

   Ages

   60 to 90

   Site

   Visionary Investigators Network, Miami, Florida

   Locations

   26 in total

   Run by

   GAP Innovations, PBC

   See if you can join NCT06584357 on ClinicalTrials.gov

4. Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

   Electrical activity in the brain known as "gamma" brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per sec…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Andrey Vyshedskiy, Miami, Florida

   Run by

   Alzheimer's Light LLC

   See if you can join NCT03657745 on ClinicalTrials.gov

5. Longitudinal Cognitive Assessment by BoCA

   The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis t…

   Stage

   Not phased

   Ages

   50 and older

   Site

   Andrey Vyshedskiy, Miami, Florida

   Run by

   Alzheimer's Light LLC

   See if you can join NCT04114994 on ClinicalTrials.gov